InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,416.00
(
-0.39%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
79.20
(
2.35%
)
Bitcoin
63,514.12
(
1.11%
)
Post# of 6490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rod5247

Send PM Follow Ignore
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

rod5247

Re: cpneln post# 5555

Monday, 03/31/2008 5:27:44 PM

Monday, March 31, 2008 5:27:44 PM

Post# of 6490
"1st step would be starting a Phase 3 with Cephalon in Italy based on the data and results collected in Italy. Then getting DNA's "blessing" to sell it off-label here in the U.S."

Insmed can not start a pivotal ALS trial. Prohibited by DNA/TRCA settlement. They can run a Phase II with Italians but Italy is waiting on Myotrophin Phase III results before possibly sponsoring a trial.

Good Luck,

Rod



Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INSM News
More INSM News
InvestorsHub NewsWire

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!